As your dynamic global partner for end-to-end biopharma services, we help you accelerate the development of novel therapies and get them to the patients who need them most.
PGDx, now a part of Labcorp, is committed to providing tailored solutions that advance your research and commercialization efforts, from early access to emerging biomarkers to custom data outputs to respective analysis.
Supporting academic and clinical oncologists
We are dedicated to helping remove financial barriers to your research — from providing quick and cost-efficient CGP solutions to exploring collaborative cost sharing.
Our CGP solid tumor assays for both tissue and blood samples are powered by proven bioinformatics and have demonstrated sensitive detection of current and emerging biomarkers as well as complex genomic signatures.
We are committed to your success, providing access to our latest technology innovations and to a team of experts that help you navigate each step of your research project.
Take a look at some of the clinical trials that have utilized PGDx solutions.